Mike Enzi actually said...

Considering that this regulation was advertised as reducing regulatory burden and saving money, it's even more disappointing.

Enzi critiques the regulation for failing to meet its promises of cost savings.

04/18/2012

More Mike Enzi Quotes

The number of drug products made outside of the United States doubled from 2001 to 2008.

Given the risks of globalization, why hasn't the FDA updated its know-your-suppliers GMPs?

Any legislation that we do, I think we have to give the secretary some latitude to prevent those suppliers from exiting the market.

I have been a strong supporter of giving FDA the tools it needs.